Skip to content

Prevalence of HIV drug resistance mutation among infant newly diagnosed with HIV infection in Thailand and associated factors in HIV vertical transmission

Prevalence of HIV drug resistance mutation among infant newly diagnosed with HIV infection in Thailand and associated factors in HIV vertical transmission

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20250306001
Enrollment
100
Registered
2025-03-06
Start date
2025-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV resistance mutation, HIV mother to child transmission HIV infection, HIV resistance mutation, mother to child transmission, triple elimination

Interventions

Children under 12 months old born to HIV-1-infected mothers defined by 1 or more positive tests for HIV DNA and/or HIV RNA PCR
Prevention
HIV MTCT

Sponsors

Faculty of Medicine, Chulalongkorn University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 12 Months

Inclusion criteria

Inclusion criteria: 1. Children under 12 months old born to HIV-1-infected mothers 2. Have HIV infection defined by > 1 positive tests for HIV DNA and/or HIV RNA PCR

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
HIV drug resistance mutation PCR for HIV DNA confirmed positive Sanger-based sequencing for protease, reverse transcriptase and integrase regions

Secondary

MeasureTime frame
patterns of HIV drug resistance mutations in HIV vertically infected infants PCR for HIV DNA confirmed positive Sanger-based sequencing for protease, reverse transcriptase and integrase regions

Countries

Thailand

Contacts

Public ContactPAVINEE ASSAVAVONGWAIKIT

Department of Pediatrics, Faculty of Medicine, Chulalongkorn University

patpvn.a@gmail.com6622564930

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026